AQR Capital Management
BRLI

AQR Capital Management’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

AQR Capital Management’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-22,656
Closed -$798K – 2309
2015
Q1 		$798K Buy
+22,656
New +$767K ﹤0.01% 1516
2014
Q2 		– Sell
-8,014
Closed -$222K – 2660
2014
Q1 		$222K Buy
+8,014
New +$210K ﹤0.01% 2392
2013
Q4 		– Sell
-7,704
Closed -$230K – 2662
2013
Q3 		$230K Sell
7,704
-29,110
-79% -$810K ﹤0.01% 2295
2013
Q2 		$1.06M Buy
+36,814
New +$1.01M ﹤0.01% 1548

Other funds holding BRLI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

AQR Capital Management's BRLI Position: Q2 2015 in Review

AQR Capital Management sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q2 2015, closing a stake of 22,656 shares — an estimated $798K sold.

AQR Capital Management first reported a position in BRLI in Q2 2013 and held it in 4 quarters. The position peaked at $1.06M in Q2 2013. 183 funds tracked by Wall St. Rank hold BRLI as of Q2 2015.

  • AQR Capital Management reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q2 2015 after selling out during the quarter.
  • AQR Capital Management sold 22,656 BIO-REFERENCE LABS INC-NEW- shares in Q2 2015, an estimated $798K.
  • AQR Capital Management first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 4 quarters.
  • AQR Capital Management's BIO-REFERENCE LABS INC-NEW- position peaked at $1.06M in Q2 2013.
  • 183 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q2 2015.

Based on AQR Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.